{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:27:27Z","timestamp":1794252447897,"version":"4.9.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["QKHJC-[2024]QN046"],"award-info":[{"award-number":["QKHJC-[2024]QN046"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["QKHJC-MS[2025]170"],"award-info":[{"award-number":["QKHJC-MS[2025]170"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2026.118583","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:06:43Z","timestamp":1768324003000},"page":"118583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Current landscape and therapeutic prospects of indole hybrids for prostate cancer treatment: A mini-review"],"prefix":"10.1016","volume":"305","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-1392","authenticated-orcid":false,"given":"Zhi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejmech.2026.118583_bib1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"issue":"10437","key":"10.1016\/j.ejmech.2026.118583_bib2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ejmech.2026.118583_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17132137","article-title":"Advances and challenges in prostate cancer diagnosis: a comprehensive review","volume":"17","author":"Kania","year":"2025","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118583_bib4","first-page":"648","article-title":"Prostate cancer diagnosis, classification and treatment overview","volume":"43","author":"Shaw","year":"2025","journal-title":"Surgery (United Kingdom)"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118583_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104384","article-title":"A review of the efficacy of prostate cancer therapies against castration-resistant prostate cancer","volume":"30","author":"Zhang","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118583_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MOU.0000000000001268","article-title":"Redefining prostate cancer care: innovations and future directions in active surveillance","volume":"35","author":"Koett","year":"2025","journal-title":"Curr. Opin. Urol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118583_bib7","first-page":"48","article-title":"Prostate cancer","volume":"51","author":"Waldron","year":"2023","journal-title":"Medicine (United Kingdom)"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118583_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41585-025-01042-6","article-title":"Synergistic targeting strategies for prostate cancer","volume":"22","author":"Li","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118583_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0115701786351199241112163708","article-title":"Indole derivatives: versatile scaffolds in drug development and cancer therapeutics","volume":"22","author":"Kulyal","year":"2025","journal-title":"Lett. Org. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118583_bib10","first-page":"724","article-title":"A privileged heterocyclic moiety in the management of cancer","volume":"25","author":"Mir","year":"2021","journal-title":"Curr. Org. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118583_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/1568026620666200908162311","article-title":"Indole alkaloids, synthetic dimers and hybrids with potential in vivo anticancer activity","volume":"21","author":"Song","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118583_bib12","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.2174\/0115701808288928240226104445","article-title":"Anti-tumor activity of indole: a review","volume":"21","author":"Mohamed","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118583_bib13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/17568919.2025.2521250","article-title":"The current landscape of indole hybrids with in vivo antitumor potential","volume":"17","author":"Ling","year":"2025","journal-title":"Future Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118583_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/17568919.2025.2504336","article-title":"An insight into the in vivo antitumor therapeutic potential of indole-(fused) pyri(mi)dine hybrids","volume":"17","author":"Xu","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112359","article-title":"Current scenario of indole derivatives with potential anti-drug-resistant cancer activity","volume":"200","author":"Jia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118449","article-title":"Indole hybrids: emerging therapeutic candidates for breast cancer (2023-2025)","volume":"303","author":"Huang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118583_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/17568919.2025.2485675","article-title":"Development of indole hybrids for potential lung cancer treatment-part I: nitrogen-containing six-membered aromatic heterocycles","volume":"17","author":"Zhao","year":"2025","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118583_bib18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17568919.2025.2485867","article-title":"Development of indole hybrids for potential lung cancer treatment-part II","volume":"17","author":"Huang","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib19","article-title":"Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors","volume":"198","author":"Albadari","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108962","article-title":"Indole-imidazolone derivatives as dual Mcl-1\/COX-2 inhibitors: design-oriented synthesis, molecular docking, and dynamics studies with potential anticancer and anti-inflammatory activities","volume":"165","author":"Lamie","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118583_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300721","article-title":"Benzimidazole-oxindole hybrids: a novel class of selective dual CDK2 and GSK-3\u03b2 inhibitors of potent anticancer activity","volume":"357","author":"Abdel-Mohsen","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.118583_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107243","article-title":"Benzimidazole-oxindole hybrids as multi-kinase inhibitors targeting melanoma","volume":"146","author":"Allam","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105358","article-title":"Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents","volume":"116","author":"Pathak","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106124","article-title":"Novel spirooxindole based benzimidazole scaffold: in vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma","volume":"129","author":"Barakat","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118583_bib25","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/s41401-021-00614-7","article-title":"Y06014 is a selective BET inhibitor for the treatment of prostate cancer","volume":"42","author":"Wu","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"40","key":"10.1016\/j.ejmech.2026.118583_bib26","doi-asserted-by":"crossref","first-page":"19442","DOI":"10.1039\/D2NJ03349F","article-title":"Regio- and stereoselective synthesis and evaluation of densely functionalized bispiro[oxindole-isoxazole-indandione] hybrids as anticancer agents","volume":"46","author":"Yin","year":"2022","journal-title":"New J. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118583_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200102","article-title":"Synthesis and evaluation of novel almazole D analogs as anticancer agents","volume":"355","author":"Oluyori","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.118583_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133789","article-title":"Design, synthesis, bioevaluation, DFT, docking, and molecular dynamic simulation for selected novel 1,3,4-Oxadiazole-indole derivatives hybrid against estrogen receptor alpha","volume":"1269","author":"Sreenatha","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"26","key":"10.1016\/j.ejmech.2026.118583_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202200972","article-title":"One-pot synthesis of some new Isatin-1,2,4-Oxadiazole hybrids as VEGFR-2 aiming anticancer agents","volume":"7","author":"Boda","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118583_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13065-024-01277-1","article-title":"Oxindole-benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation","volume":"18","author":"Abdel-Mohsen","year":"2024","journal-title":"BMC Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118583_bib31","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1021\/acs.jmedchem.4c01255","article-title":"Targeting hTERT promoter G-Quadruplex DNA structures with small-molecule ligand to downregulate hTERT expression for triple-negative breast cancer therapy","volume":"67","author":"Long","year":"2024","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118583_bib32","first-page":"8094","article-title":"Synthesis, antibacterial and anticancer activities evaluation of new 4-thiazolidinone-indolin-2-one analogs","volume":"12","author":"Hamzehloueian","year":"2022","journal-title":"Biointerf. Res. Appl. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118583_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202405049","article-title":"Dynole-based dynamin inhibitors as novel cytotoxic agents","volume":"10","author":"Sakoff","year":"2025","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118583_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2163393","article-title":"Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells","volume":"38","author":"Zhang","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107626","article-title":"Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2\/STAT-3 inhibitors: design, synthesis and biological assessments","volume":"151","author":"Elsebaie","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202404601","article-title":"Design and synthesis of Isatin-1,2,3-triazole hybrids as anticancer agents","volume":"9","author":"Mohite","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118583_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101536","article-title":"An efficient synthesis and anticancer evaluation of 1,2,3-triazolo-indole-2-carboxylate derivatives","volume":"7","author":"Anantoju","year":"2024","journal-title":"Results Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203778","article-title":"Synthesis, anticancer activity and molecular docking studies of hybrid molecules containing Indole- thiazolidinedione-triazole moieties","volume":"7","author":"Perike","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118583_bib39","article-title":"Discovery of novel diarylamide N-Containing heterocyclic derivatives as new tubulin polymerization inhibitors with anti-cancer activity","volume":"26","author":"Liu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118583_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ph18020275","article-title":"Design, synthesis, and antiproliferative activity of novel Indole\/1,2,4-Triazole hybrids as tubulin polymerization inhibitors","volume":"18","author":"Mahmoud","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.118583_bib41","doi-asserted-by":"crossref","first-page":"21869","DOI":"10.1039\/D1NJ03892C","article-title":"Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anticancer activity","volume":"45","author":"Yang","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib42","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.6023\/cjoc202008057","article-title":"Novel 3-Thioether-4-indolimino-4H-1,2,4-triazole derivatives bearing pyridyl moiety: design, synthesis and bioactivity evaluation","volume":"41","author":"Qi","year":"2021","journal-title":"in vitro. Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114637","article-title":"Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors","volume":"241","author":"Espadinha","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib44","article-title":"One-Pot synthesis of isatin-pyrazole hybrids as VEGFR-2 inhibitors and molecular docking studies","volume":"8","author":"Reddy","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118583_bib45","article-title":"Design, synthesis and structure-activity relationship studies of Meridianin derivatives as novel JAK\/STAT3 signaling inhibitors","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118583_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.6023\/cjo202006054","article-title":"Design, synthesis and anticancer activity studies of novel indole-pyrimidine biaryl derivatives","volume":"41","author":"Zhang","year":"2021","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105918","article-title":"Design, synthesis, and biological evaluation of pseudo-bicyclic pyrimidine-based compounds as potential EGFR inhibitors","volume":"126","author":"Farag","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128651","article-title":"Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitors","volume":"63","author":"Chen","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118583_bib49","article-title":"Synthesis and anticancer evaluation of benzylated indole based alkyl-substituted Pyrido[2,3-d]Pyrimidines targeting thymidylate synthase","volume":"9","author":"Kumar","year":"2024","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.118583_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107963","article-title":"Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instability","volume":"153","author":"Yu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115470","article-title":"Discovery of novel N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as the inhibitors of tubulin polymerization in leukemia cells","volume":"256","author":"Wu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jare.2024.03.002","article-title":"Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Ka inhibitors","volume":"68","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.118583_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030333","article-title":"Novel indole-tethered chromene derivatives: synthesis, cytotoxic properties, and key computational insights","volume":"16","author":"Malik","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118583_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031481","article-title":"Novel indole-containing hybrids derived from millepachine: synthesis, biological evaluation and antitumor mechanism study","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118583_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173975","article-title":"MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma","volume":"898","author":"Yan","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118583_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114467","article-title":"Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities","volume":"238","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118583_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11030-023-10605-x","article-title":"Design, synthesis, and anticancer evaluation of 1-benzo[1,3]dioxol-5-yl-3-N-fused heteroaryl indoles","volume":"28","author":"Yao","year":"2024","journal-title":"Mol. Diversity"},{"issue":"21","key":"10.1016\/j.ejmech.2026.118583_bib58","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc-2023-0151","article-title":"Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors","volume":"15","author":"Zhang","year":"2023","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118583_bib59","article-title":"7-Chloroquinolinehydrazones as first-in-class anticancer experimental drugs in the NCI-60 screen among different investigated series of aryl, Quinoline, pyridine, benzothiazole and imidazolehydrazones","volume":"16","author":"Negru","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1016\/j.ejmech.2026.118583_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30193988","article-title":"Discovery of primaquine-indole carboxamides with cancer-cell-selective antiproliferative activity","volume":"30","author":"Peer","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118583_bib61","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1021\/acs.jmedchem.1c00681","article-title":"Development of 2-(5,6,7-Trifluoro-1H-Indol-3-yl)-quinoline-5- carboxamide as a potent, selective, and orally available inhibitor of human androgen receptor targeting its binding Function-3 for the treatment of castration-resistant prostate cancer","volume":"64","author":"Leblanc","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115274","article-title":"Antitumor effect of 3-(quinolin-2-ylmethylene)-4,6-dimethyl-5-hydroxy-7-azaoxindole down-regulating the Gas6-Axl axis","volume":"251","author":"Bae","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib63","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1055\/s-0042-1743487","article-title":"Design, synthesis, and evaluation of Benzoheterocyclic-Containing derivatives as novel HDAC1 inhibitors","volume":"4","author":"Jiao","year":"2022","journal-title":"Pharmaceut. Fronts."},{"key":"10.1016\/j.ejmech.2026.118583_bib64","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1055\/s-0042-1749373","article-title":"Discovery of indole-containing benzamide derivatives as HDAC1 inhibitors with in vitro and in vivo antitumor activities","volume":"4","author":"Gu","year":"2022","journal-title":"Pharmaceut. Fronts."},{"key":"10.1016\/j.ejmech.2026.118583_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117963","article-title":"Amino acid-modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer","volume":"297","author":"El-Haggar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300562","article-title":"Design, synthesis, and antiproliferative activity of new indole\/1,2,4-triazole\/chalcone hybrids as EGFR and\/or c-MET inhibitors","volume":"357","author":"Mahmoud","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.118583_bib67","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1039\/D4RA06796G","article-title":"L-Proline catalysed synthesis and in silico studies of novel a-cyano bis(indolyl)chalcones as potential anti-cancer agents","volume":"15","author":"Malik","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.118583_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117459","article-title":"Design, synthesis and anticancer activity of N-aryl indolylsulfoximines: identification of potent and selective anticancer agents","volume":"93","author":"Malik","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108494","article-title":"Novel benzofuran-conjugated indolin-2-ones as anticancer agents; design, synthesis, biological assessments, and molecular modeling insights","volume":"160","author":"Eldehna","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118583_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200372","article-title":"Design, synthesis and cytotoxicity evaluation of novel indole derivatives of panaxadiol","volume":"19","author":"Han","year":"2022","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.ejmech.2026.118583_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129045","article-title":"Novel ginsenoside derivatives induce apoptosis in HepG-2 cells via the MDM2-p53 signaling pathway","volume":"78","author":"Teng","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:47:06Z","timestamp":1773971226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":71,"alternative-id":["S0223523426000280"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118583","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current landscape and therapeutic prospects of indole hybrids for prostate cancer treatment: A mini-review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118583"}}